{"gene":"VWA8","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2017,"finding":"VWA8 protein is targeted exclusively to mitochondria via a mitochondrial targeting sequence (MTS); deletion of the MTS redirects VWA8 to the cytosol. The short isoform (VWA8b) expressed in insect cells has in vitro ATPase activity, and deletion of either the Walker A or Walker B motif mostly abolishes this activity, establishing these motifs as essential for ATPase function.","method":"Confocal microscopy (MTS deletion), baculovirus/insect cell expression with in vitro ATPase assay, Walker motif mutagenesis, homology modeling","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro ATPase assay with active-site mutagenesis (Walker A/B deletion) and direct localization experiment with functional consequence (MTS deletion), multiple orthogonal methods in a single study","pmids":["28414126"],"is_preprint":false},{"year":2019,"finding":"VWA8 localizes to the matrix side of the inner mitochondrial membrane, as demonstrated by differential sub-fractionation of rat liver mitochondria; its 34-amino-acid N-terminal Matrix-Targeting Signal (vMTS) is essential for mitochondrial localization, as deletion of vMTS causes cytosolic redistribution in C2C12 myoblasts.","method":"Differential sub-fractionation of isolated rat liver mitochondria, confocal microscopy in C2C12 cells with vMTS deletion construct","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct subcellular fractionation plus confocal imaging with deletion mutant, two orthogonal methods, single lab","pmids":["31630795"],"is_preprint":false},{"year":2019,"finding":"CRISPR/Cas9 deletion of VWA8 in mouse AML12 hepatocytes leads to elevated ROS production (localized to peroxisomes and NOX1/4), increased oxidative stress and protein degradation (metabolomics), upregulation of mitochondrial ETC Complex I, ATP synthase, peroxisomal, and lipid transport proteins (proteomics/transcriptomics), and higher HNF4α expression. Rescue with VWA8 protein restored the wild-type phenotype, and antioxidant treatment reduced HNF4α levels, placing VWA8 upstream of a ROS–HNF4α axis and consistent with a role in mitochondrial protein quality control.","method":"CRISPR/Cas9 KO in AML12 cells, metabolomics, proteomics, transcriptomics, H2O2/ROS assays, bioenergetic assays, inhibitor experiments, genetic rescue","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal omics plus functional rescue, loss-of-function with specific phenotypic readout, inhibitor localization of ROS source, single lab but rigorous multi-method design","pmids":["31702900"],"is_preprint":false},{"year":2021,"finding":"CRISPR/Cas9 deletion of VWA8 in AML12 hepatocytes increases the enzymatic activities of ETC complexes I, II, III, and IV, and doubles both cristae density and mitochondrial area as measured by electron microscopy and stereology, demonstrating that VWA8 normally restrains the global mitochondrial oxidative capacity and cristae biogenesis.","method":"CRISPR/Cas9 KO, spectrophotometric ETC complex activity assays, electron microscopy with stereological quantification, proteomics comparison","journal":"Biochemistry and biophysics reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct enzymatic activity assays plus ultrastructural quantification plus proteomics corroboration, multiple orthogonal methods, single lab","pmids":["33665377"],"is_preprint":false},{"year":2018,"finding":"P7BP2 (identical to VWA8) binds the PTS2 receptor Pex7 and is transported into peroxisomes via Pex5pL–Pex7p; this peroxisomal localization depends on a cleavable PTS2 in the N-terminal region. The protein behaves as a monomer by gel filtration but adopts a disc-like ring structure under atomic force microscopy, suggesting a pseudo-hexameric arrangement consistent with dynein-type AAA+ proteins.","method":"Co-immunoprecipitation/binding assay with Pex7, peroxisomal import assay, PTS2 deletion, gel-filtration chromatography, atomic force microscopy","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding and localization experiments with deletion of targeting signal, AFM structural visualization; single lab, limited mechanistic follow-up beyond localization","pmids":["30204880"],"is_preprint":false},{"year":2023,"finding":"VWA8 knockdown in zebrafish causes severe mitochondrial damage, excessive mitophagy, and activation of apoptosis in the retina, indicating that VWA8 is required for mitochondrial integrity and that its loss triggers aberrant mitophagy as the pathogenic mechanism in retinitis pigmentosa.","method":"Zebrafish morpholino knockdown, cellular/molecular analysis of mitochondrial damage, mitophagy, and apoptosis markers","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — zebrafish KD with defined phenotypic and molecular readouts (mitophagy, apoptosis), single lab, single model organism","pmids":["37012052"],"is_preprint":false},{"year":2021,"finding":"VWA8 morpholino knockdown in zebrafish produces delayed early development, lack of movement, light sensitivity, scoliosis, facial dysmorphism, and cardiovascular malformations, establishing a role for VWA8 in early development and skeletal morphogenesis.","method":"Zebrafish morpholino knockdown with developmental and skeletal phenotypic assessment","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — morpholino KD in zebrafish with clear phenotypic readouts; single lab, no molecular mechanism beyond phenotype description","pmids":["34660594"],"is_preprint":false}],"current_model":"VWA8 is a mitochondrial matrix AAA+ ATPase that localizes to the matrix face of the inner mitochondrial membrane via a cleavable N-terminal targeting sequence; its Walker A and Walker B motifs are essential for ATPase activity, and loss of VWA8 elevates ROS production (via NOX4/peroxisomes), activates an HNF4α compensatory transcriptional response, and globally increases ETC complex activities and cristae density, suggesting VWA8 normally acts as a brake on mitochondrial oxidative capacity and plays a role in mitochondrial protein quality control; in addition, a fraction of VWA8 localizes to peroxisomes via a PTS2/Pex7-dependent import pathway, and VWA8 deficiency in vivo causes excessive mitophagy, apoptosis, and developmental defects including retinal degeneration and skeletal malformations."},"narrative":{"mechanistic_narrative":"VWA8 is a AAA+ ATPase that acts as a negative regulator of mitochondrial oxidative capacity and contributes to mitochondrial protein quality control [PMID:31702900, PMID:33665377]. The protein is targeted predominantly to the mitochondrial matrix face of the inner membrane via a cleavable 34-residue N-terminal matrix-targeting signal, whose deletion redirects the protein to the cytosol [PMID:28414126, PMID:31630795]. Its ATPase activity depends on intact Walker A and Walker B motifs, deletion of which abolishes catalysis in vitro [PMID:28414126]. Loss of VWA8 in hepatocytes elevates ROS production localized to peroxisomes and NOX1/4, drives a compensatory HNF4α transcriptional response downstream of this ROS signal, and globally increases ETC complex I–IV activities together with doubled cristae density and mitochondrial area—placing VWA8 as a brake on oxidative metabolism and cristae biogenesis [PMID:31702900, PMID:33665377]. A fraction of the protein is additionally imported into peroxisomes through a PTS2/Pex7-dependent pathway, where it adopts a disc-like ring structure consistent with a pseudo-hexameric dynein-type AAA+ arrangement [PMID:30204880]. In vivo, VWA8 depletion in zebrafish causes mitochondrial damage with excessive mitophagy and apoptosis in the retina, linking it to retinitis pigmentosa, and produces early developmental, skeletal, and cardiovascular malformations [PMID:37012052, PMID:34660594].","teleology":[{"year":2017,"claim":"Established that VWA8 is a mitochondrially targeted protein with intrinsic, Walker-motif-dependent ATPase activity, defining it as a functional AAA+ ATPase rather than an inactive paralog.","evidence":"Confocal imaging of MTS-deletion constructs plus in vitro ATPase assay of insect-cell-expressed isoform with Walker A/B mutagenesis","pmids":["28414126"],"confidence":"High","gaps":["No physiological substrate or unfoldase activity demonstrated","Submitochondrial location not yet resolved in this study"]},{"year":2018,"claim":"Showed that VWA8 (P7BP2) is also imported into peroxisomes via a PTS2/Pex7-dependent route and visualized a disc-like ring structure, implying an oligomeric AAA+ architecture and a dual-organelle localization.","evidence":"Pex7 binding/Co-IP, peroxisomal import and PTS2-deletion assays, gel filtration, atomic force microscopy","pmids":["30204880"],"confidence":"Medium","gaps":["Pseudo-hexameric arrangement inferred from AFM, not solved structure","Functional role of the peroxisomal pool undefined","Relationship between mitochondrial and peroxisomal targeting signals unresolved"]},{"year":2019,"claim":"Localized VWA8 to the matrix side of the inner mitochondrial membrane and mapped its 34-residue matrix-targeting signal, pinning down where the ATPase acts.","evidence":"Differential sub-fractionation of rat liver mitochondria and confocal imaging of vMTS-deletion constructs in C2C12 cells","pmids":["31630795"],"confidence":"High","gaps":["Mechanism of membrane association not defined","No interacting partner at the inner membrane identified"]},{"year":2019,"claim":"Defined the loss-of-function phenotype: VWA8 deletion raises ROS, triggers oxidative stress and protein degradation, and activates an HNF4α response, positioning VWA8 upstream of a ROS–HNF4α axis and consistent with a protein quality control role.","evidence":"CRISPR/Cas9 KO in AML12 hepatocytes with metabolomics, proteomics, transcriptomics, ROS assays, inhibitor localization, and genetic rescue","pmids":["31702900"],"confidence":"High","gaps":["Direct quality-control substrates not identified","Mechanism linking VWA8 loss to NOX/peroxisomal ROS source unresolved"]},{"year":2021,"claim":"Demonstrated that VWA8 restrains global mitochondrial oxidative capacity, since its loss increases all four ETC complex activities and doubles cristae density and mitochondrial area.","evidence":"CRISPR/Cas9 KO with spectrophotometric ETC activity assays, electron microscopy with stereology, and proteomics","pmids":["33665377"],"confidence":"High","gaps":["Molecular mechanism by which an ATPase limits ETC activity unknown","Causal link between cristae expansion and ROS phenotype not established"]},{"year":2021,"claim":"Connected VWA8 to organismal development, showing knockdown causes early developmental delay plus skeletal and cardiovascular malformations.","evidence":"Zebrafish morpholino knockdown with developmental and skeletal phenotyping","pmids":["34660594"],"confidence":"Medium","gaps":["Morpholino specificity not corroborated by genetic mutant","No molecular mechanism linking mitochondrial defect to morphogenesis"]},{"year":2023,"claim":"Identified excessive mitophagy and apoptosis from mitochondrial damage as the pathogenic mechanism of VWA8 loss in the retina, linking the gene to retinitis pigmentosa.","evidence":"Zebrafish morpholino knockdown with mitochondrial damage, mitophagy, and apoptosis marker analysis","pmids":["37012052"],"confidence":"Medium","gaps":["Mitophagy pathway mediating the effect not delineated","Human disease causation rests on knockdown rather than patient-mutation rescue"]},{"year":null,"claim":"The direct molecular substrate(s) of VWA8 ATPase activity and the biochemical mechanism by which it brakes ETC activity and supports protein quality control remain unknown.","evidence":"No timeline study reconstitutes substrate engagement or unfoldase action","pmids":[],"confidence":"Low","gaps":["No identified substrate or partner protein at the inner membrane","Functional role of peroxisomal pool versus mitochondrial pool undefined","No high-resolution structure of the oligomer"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005777","term_label":"peroxisome","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3]}],"complexes":[],"partners":["PEX7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"A3KMH1","full_name":"von Willebrand factor A domain-containing protein 8","aliases":["PEX7-binding protein 2","P7BP2"],"length_aa":1905,"mass_kda":214.8,"function":"Exhibits ATPase activity in vitro","subcellular_location":"Mitochondrion; Peroxisome","url":"https://www.uniprot.org/uniprotkb/A3KMH1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/VWA8","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"RPP30","stoichiometry":4.0},{"gene":"HNRNPH1","stoichiometry":0.2},{"gene":"NXT2","stoichiometry":0.2},{"gene":"TSR1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/VWA8","total_profiled":1310},"omim":[{"mim_id":"620422","title":"RETINITIS PIGMENTOSA 97; RP97","url":"https://www.omim.org/entry/620422"},{"mim_id":"619689","title":"SPERMATOGENIC FAILURE 63; SPGF63","url":"https://www.omim.org/entry/619689"},{"mim_id":"619655","title":"RIBOSOMAL PROTEIN L10-LIKE; RPL10L","url":"https://www.omim.org/entry/619655"},{"mim_id":"617509","title":"VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 8; VWA8","url":"https://www.omim.org/entry/617509"},{"mim_id":"268000","title":"RETINITIS PIGMENTOSA; RP","url":"https://www.omim.org/entry/268000"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Lipid droplets","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/VWA8"},"hgnc":{"alias_symbol":["P7BP2"],"prev_symbol":["KIAA0564"]},"alphafold":{"accession":"A3KMH1","domains":[{"cath_id":"3.40.50.300","chopping":"54-266","consensus_level":"high","plddt":87.178,"start":54,"end":266},{"cath_id":"-","chopping":"284-372","consensus_level":"medium","plddt":84.312,"start":284,"end":372},{"cath_id":"3.40.50.300","chopping":"374-535_573-610","consensus_level":"medium","plddt":82.854,"start":374,"end":610},{"cath_id":"-","chopping":"641-712","consensus_level":"medium","plddt":82.2782,"start":641,"end":712},{"cath_id":"3.40.50.300","chopping":"733-930","consensus_level":"medium","plddt":82.1349,"start":733,"end":930},{"cath_id":"-","chopping":"936-959_971-1029","consensus_level":"medium","plddt":81.8377,"start":936,"end":1029},{"cath_id":"3.40.50.410","chopping":"1647-1665_1707-1904","consensus_level":"high","plddt":80.6902,"start":1647,"end":1904},{"cath_id":"-","chopping":"1669-1701","consensus_level":"high","plddt":69.613,"start":1669,"end":1701}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/A3KMH1","model_url":"https://alphafold.ebi.ac.uk/files/AF-A3KMH1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-A3KMH1-F1-predicted_aligned_error_v6.png","plddt_mean":78.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=VWA8","jax_strain_url":"https://www.jax.org/strain/search?query=VWA8"},"sequence":{"accession":"A3KMH1","fasta_url":"https://rest.uniprot.org/uniprotkb/A3KMH1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/A3KMH1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/A3KMH1"}},"corpus_meta":[{"pmid":"28414126","id":"PMC_28414126","title":"Characterization of the novel protein KIAA0564 (Von Willebrand Domain-containing Protein 8).","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28414126","citation_count":18,"is_preprint":false},{"pmid":"34660594","id":"PMC_34660594","title":"Mutated VWA8 Is Associated With Developmental Delay, Microcephaly, and Scoliosis and Plays a Novel Role in Early Development and Skeletal Morphogenesis in Zebrafish.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34660594","citation_count":16,"is_preprint":false},{"pmid":"31702900","id":"PMC_31702900","title":"Deletion of the Mitochondrial Protein VWA8 Induces Oxidative Stress and an HNF4α Compensatory Response in Hepatocytes.","date":"2019","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31702900","citation_count":14,"is_preprint":false},{"pmid":"31630795","id":"PMC_31630795","title":"Von Willebrand factor A domain-containing protein 8 (VWA8) localizes to the matrix side of the inner mitochondrial membrane.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31630795","citation_count":12,"is_preprint":false},{"pmid":"37012052","id":"PMC_37012052","title":"Mutations in VWA8 cause autosomal-dominant retinitis pigmentosa via aberrant mitophagy activation.","date":"2023","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37012052","citation_count":8,"is_preprint":false},{"pmid":"29660410","id":"PMC_29660410","title":"The spatial and developmental expression of mouse Vwa8 (von Willebrand domain-containing protein 8).","date":"2018","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/29660410","citation_count":7,"is_preprint":false},{"pmid":"33665377","id":"PMC_33665377","title":"Deletion of Von Willebrand A Domain Containing Protein (VWA8) raises activity of mitochondrial electron transport chain complexes in hepatocytes.","date":"2021","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/33665377","citation_count":4,"is_preprint":false},{"pmid":"30204880","id":"PMC_30204880","title":"A newly isolated Pex7-binding, atypical PTS2 protein P7BP2 is a novel dynein-type AAA+ protein.","date":"2018","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30204880","citation_count":3,"is_preprint":false},{"pmid":"38691277","id":"PMC_38691277","title":"Circular RNA KIAA0564 Serves as a Competitive Endogenous RNA for MicroRNA-424-5p, Mediating the Expression of Lysine Demethylase 4a, Thereby Facilitating Intervertebral Disc Degeneration.","date":"2024","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/38691277","citation_count":2,"is_preprint":false},{"pmid":"39684278","id":"PMC_39684278","title":"The Oncogenic Role of VWA8-AS1, a Long Non-Coding RNA, in Epstein-Barr Virus-Associated Oral Squamous Cell Carcinoma: An Integrative Transcriptome and Functional Analysis.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39684278","citation_count":2,"is_preprint":false},{"pmid":"41151836","id":"PMC_41151836","title":"Genetic haplotypes in VWA8, OSBPL6, and ADAMTS9-AS2 are associated with immune-related adverse effects in ICI-treated patients with cancer.","date":"2025","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/41151836","citation_count":0,"is_preprint":false},{"pmid":"41751584","id":"PMC_41751584","title":"Classification of SINE Tails in the Porcine Genome and Its Potential Impact on VWA8 Gene.","date":"2026","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/41751584","citation_count":0,"is_preprint":false},{"pmid":"40638000","id":"PMC_40638000","title":"von Willebrand factor A domain containing 8 (VWA8)- associated retinitis pigmentosa: description of a novel case and expansion of the phenotype.","date":"2025","source":"International ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/40638000","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9073,"output_tokens":2033,"usd":0.028857,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9061,"output_tokens":2651,"usd":0.05579,"stage2_stop_reason":"end_turn"},"total_usd":0.084647,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"VWA8 protein is targeted exclusively to mitochondria via a mitochondrial targeting sequence (MTS); deletion of the MTS redirects VWA8 to the cytosol. The short isoform (VWA8b) expressed in insect cells has in vitro ATPase activity, and deletion of either the Walker A or Walker B motif mostly abolishes this activity, establishing these motifs as essential for ATPase function.\",\n      \"method\": \"Confocal microscopy (MTS deletion), baculovirus/insect cell expression with in vitro ATPase assay, Walker motif mutagenesis, homology modeling\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro ATPase assay with active-site mutagenesis (Walker A/B deletion) and direct localization experiment with functional consequence (MTS deletion), multiple orthogonal methods in a single study\",\n      \"pmids\": [\"28414126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"VWA8 localizes to the matrix side of the inner mitochondrial membrane, as demonstrated by differential sub-fractionation of rat liver mitochondria; its 34-amino-acid N-terminal Matrix-Targeting Signal (vMTS) is essential for mitochondrial localization, as deletion of vMTS causes cytosolic redistribution in C2C12 myoblasts.\",\n      \"method\": \"Differential sub-fractionation of isolated rat liver mitochondria, confocal microscopy in C2C12 cells with vMTS deletion construct\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular fractionation plus confocal imaging with deletion mutant, two orthogonal methods, single lab\",\n      \"pmids\": [\"31630795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRISPR/Cas9 deletion of VWA8 in mouse AML12 hepatocytes leads to elevated ROS production (localized to peroxisomes and NOX1/4), increased oxidative stress and protein degradation (metabolomics), upregulation of mitochondrial ETC Complex I, ATP synthase, peroxisomal, and lipid transport proteins (proteomics/transcriptomics), and higher HNF4α expression. Rescue with VWA8 protein restored the wild-type phenotype, and antioxidant treatment reduced HNF4α levels, placing VWA8 upstream of a ROS–HNF4α axis and consistent with a role in mitochondrial protein quality control.\",\n      \"method\": \"CRISPR/Cas9 KO in AML12 cells, metabolomics, proteomics, transcriptomics, H2O2/ROS assays, bioenergetic assays, inhibitor experiments, genetic rescue\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal omics plus functional rescue, loss-of-function with specific phenotypic readout, inhibitor localization of ROS source, single lab but rigorous multi-method design\",\n      \"pmids\": [\"31702900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CRISPR/Cas9 deletion of VWA8 in AML12 hepatocytes increases the enzymatic activities of ETC complexes I, II, III, and IV, and doubles both cristae density and mitochondrial area as measured by electron microscopy and stereology, demonstrating that VWA8 normally restrains the global mitochondrial oxidative capacity and cristae biogenesis.\",\n      \"method\": \"CRISPR/Cas9 KO, spectrophotometric ETC complex activity assays, electron microscopy with stereological quantification, proteomics comparison\",\n      \"journal\": \"Biochemistry and biophysics reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct enzymatic activity assays plus ultrastructural quantification plus proteomics corroboration, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"33665377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"P7BP2 (identical to VWA8) binds the PTS2 receptor Pex7 and is transported into peroxisomes via Pex5pL–Pex7p; this peroxisomal localization depends on a cleavable PTS2 in the N-terminal region. The protein behaves as a monomer by gel filtration but adopts a disc-like ring structure under atomic force microscopy, suggesting a pseudo-hexameric arrangement consistent with dynein-type AAA+ proteins.\",\n      \"method\": \"Co-immunoprecipitation/binding assay with Pex7, peroxisomal import assay, PTS2 deletion, gel-filtration chromatography, atomic force microscopy\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding and localization experiments with deletion of targeting signal, AFM structural visualization; single lab, limited mechanistic follow-up beyond localization\",\n      \"pmids\": [\"30204880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"VWA8 knockdown in zebrafish causes severe mitochondrial damage, excessive mitophagy, and activation of apoptosis in the retina, indicating that VWA8 is required for mitochondrial integrity and that its loss triggers aberrant mitophagy as the pathogenic mechanism in retinitis pigmentosa.\",\n      \"method\": \"Zebrafish morpholino knockdown, cellular/molecular analysis of mitochondrial damage, mitophagy, and apoptosis markers\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — zebrafish KD with defined phenotypic and molecular readouts (mitophagy, apoptosis), single lab, single model organism\",\n      \"pmids\": [\"37012052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"VWA8 morpholino knockdown in zebrafish produces delayed early development, lack of movement, light sensitivity, scoliosis, facial dysmorphism, and cardiovascular malformations, establishing a role for VWA8 in early development and skeletal morphogenesis.\",\n      \"method\": \"Zebrafish morpholino knockdown with developmental and skeletal phenotypic assessment\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — morpholino KD in zebrafish with clear phenotypic readouts; single lab, no molecular mechanism beyond phenotype description\",\n      \"pmids\": [\"34660594\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"VWA8 is a mitochondrial matrix AAA+ ATPase that localizes to the matrix face of the inner mitochondrial membrane via a cleavable N-terminal targeting sequence; its Walker A and Walker B motifs are essential for ATPase activity, and loss of VWA8 elevates ROS production (via NOX4/peroxisomes), activates an HNF4α compensatory transcriptional response, and globally increases ETC complex activities and cristae density, suggesting VWA8 normally acts as a brake on mitochondrial oxidative capacity and plays a role in mitochondrial protein quality control; in addition, a fraction of VWA8 localizes to peroxisomes via a PTS2/Pex7-dependent import pathway, and VWA8 deficiency in vivo causes excessive mitophagy, apoptosis, and developmental defects including retinal degeneration and skeletal malformations.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"VWA8 is a AAA+ ATPase that acts as a negative regulator of mitochondrial oxidative capacity and contributes to mitochondrial protein quality control [#2, #3]. The protein is targeted predominantly to the mitochondrial matrix face of the inner membrane via a cleavable 34-residue N-terminal matrix-targeting signal, whose deletion redirects the protein to the cytosol [#0, #1]. Its ATPase activity depends on intact Walker A and Walker B motifs, deletion of which abolishes catalysis in vitro [#0]. Loss of VWA8 in hepatocytes elevates ROS production localized to peroxisomes and NOX1/4, drives a compensatory HNF4\\u03b1 transcriptional response downstream of this ROS signal, and globally increases ETC complex I\\u2013IV activities together with doubled cristae density and mitochondrial area\\u2014placing VWA8 as a brake on oxidative metabolism and cristae biogenesis [#2, #3]. A fraction of the protein is additionally imported into peroxisomes through a PTS2/Pex7-dependent pathway, where it adopts a disc-like ring structure consistent with a pseudo-hexameric dynein-type AAA+ arrangement [#4]. In vivo, VWA8 depletion in zebrafish causes mitochondrial damage with excessive mitophagy and apoptosis in the retina, linking it to retinitis pigmentosa, and produces early developmental, skeletal, and cardiovascular malformations [#5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2017,\n      \"claim\": \"Established that VWA8 is a mitochondrially targeted protein with intrinsic, Walker-motif-dependent ATPase activity, defining it as a functional AAA+ ATPase rather than an inactive paralog.\",\n      \"evidence\": \"Confocal imaging of MTS-deletion constructs plus in vitro ATPase assay of insect-cell-expressed isoform with Walker A/B mutagenesis\",\n      \"pmids\": [\"28414126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No physiological substrate or unfoldase activity demonstrated\", \"Submitochondrial location not yet resolved in this study\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed that VWA8 (P7BP2) is also imported into peroxisomes via a PTS2/Pex7-dependent route and visualized a disc-like ring structure, implying an oligomeric AAA+ architecture and a dual-organelle localization.\",\n      \"evidence\": \"Pex7 binding/Co-IP, peroxisomal import and PTS2-deletion assays, gel filtration, atomic force microscopy\",\n      \"pmids\": [\"30204880\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pseudo-hexameric arrangement inferred from AFM, not solved structure\", \"Functional role of the peroxisomal pool undefined\", \"Relationship between mitochondrial and peroxisomal targeting signals unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Localized VWA8 to the matrix side of the inner mitochondrial membrane and mapped its 34-residue matrix-targeting signal, pinning down where the ATPase acts.\",\n      \"evidence\": \"Differential sub-fractionation of rat liver mitochondria and confocal imaging of vMTS-deletion constructs in C2C12 cells\",\n      \"pmids\": [\"31630795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of membrane association not defined\", \"No interacting partner at the inner membrane identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the loss-of-function phenotype: VWA8 deletion raises ROS, triggers oxidative stress and protein degradation, and activates an HNF4\\u03b1 response, positioning VWA8 upstream of a ROS\\u2013HNF4\\u03b1 axis and consistent with a protein quality control role.\",\n      \"evidence\": \"CRISPR/Cas9 KO in AML12 hepatocytes with metabolomics, proteomics, transcriptomics, ROS assays, inhibitor localization, and genetic rescue\",\n      \"pmids\": [\"31702900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct quality-control substrates not identified\", \"Mechanism linking VWA8 loss to NOX/peroxisomal ROS source unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated that VWA8 restrains global mitochondrial oxidative capacity, since its loss increases all four ETC complex activities and doubles cristae density and mitochondrial area.\",\n      \"evidence\": \"CRISPR/Cas9 KO with spectrophotometric ETC activity assays, electron microscopy with stereology, and proteomics\",\n      \"pmids\": [\"33665377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which an ATPase limits ETC activity unknown\", \"Causal link between cristae expansion and ROS phenotype not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected VWA8 to organismal development, showing knockdown causes early developmental delay plus skeletal and cardiovascular malformations.\",\n      \"evidence\": \"Zebrafish morpholino knockdown with developmental and skeletal phenotyping\",\n      \"pmids\": [\"34660594\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Morpholino specificity not corroborated by genetic mutant\", \"No molecular mechanism linking mitochondrial defect to morphogenesis\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified excessive mitophagy and apoptosis from mitochondrial damage as the pathogenic mechanism of VWA8 loss in the retina, linking the gene to retinitis pigmentosa.\",\n      \"evidence\": \"Zebrafish morpholino knockdown with mitochondrial damage, mitophagy, and apoptosis marker analysis\",\n      \"pmids\": [\"37012052\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mitophagy pathway mediating the effect not delineated\", \"Human disease causation rests on knockdown rather than patient-mutation rescue\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct molecular substrate(s) of VWA8 ATPase activity and the biochemical mechanism by which it brakes ETC activity and supports protein quality control remain unknown.\",\n      \"evidence\": \"No timeline study reconstitutes substrate engagement or unfoldase action\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No identified substrate or partner protein at the inner membrane\", \"Functional role of peroxisomal pool versus mitochondrial pool undefined\", \"No high-resolution structure of the oligomer\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0016887\" , \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PEX7\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":6,"faith_total":6,"faith_pct":100.0}}